82 related articles for article (PubMed ID: 7987066)
1. Proliferating cell nuclear antigen expression in Wistar rat livers. A retrospective immunohistochemical study of normal and neoplastic livers.
Perentes E; Arnold J; Meier G; Ettlin RA; Karamitopoulou E; Prentice DE
Exp Toxicol Pathol; 1994 Jul; 46(2):105-10. PubMed ID: 7987066
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
Mun KS; Cheah PL; Baharudin NB; Looi LM
Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
[TBL] [Abstract][Full Text] [Related]
3. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
5. The expression of c-kit and proliferating cell nuclear antigen in oval cells of rats with hepatocellular carcinoma.
Fang CH; Zhang W; Zhu XY; Gong JQ; Zhang GQ
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):537-44. PubMed ID: 14627515
[TBL] [Abstract][Full Text] [Related]
6. Quantification of hepatocytic proliferation in the laboratory mouse. A comparative study using immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression.
Lardelli P; Perentes E; Meier G; Navarro N; Ettlin RA
Exp Toxicol Pathol; 1994 Jul; 46(2):95-100. PubMed ID: 7987078
[TBL] [Abstract][Full Text] [Related]
7. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration.
Andiran F; Ayhan A; Tanyel FC; Abbasoğlu O; Sayek I
J Surg Res; 2000 Apr; 89(2):184-8. PubMed ID: 10729248
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
[TBL] [Abstract][Full Text] [Related]
11. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.
Karamitopoulou E; Perentes E; Melachrinou M; Maraziotis T
Acta Neuropathol; 1993; 85(3):316-22. PubMed ID: 7681617
[TBL] [Abstract][Full Text] [Related]
14. Scanning microfluorometric analysis of proliferating cell nuclear antigen in formalin-fixed sections of hyperplastic and neoplastic rat liver.
Kong J; Ringer DP
Cytometry; 1995 May; 20(1):86-93. PubMed ID: 7600903
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
Harrison RF; Reynolds GM; Rowlands DC
J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
[TBL] [Abstract][Full Text] [Related]
18. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]